These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Major developments in clinical chemical instrumentation. Caraway WT J Clin Chem Clin Biochem; 1981 Jul; 19(7):491-6. PubMed ID: 7035606 [TBL] [Abstract][Full Text] [Related]
44. The Abbott Architect c8000: analytical performance and productivity characteristics of a new analyzer applied to general chemistry testing. Pauli D; Seyfarth M; Dibbelt L Clin Lab; 2005; 51(1-2):31-41. PubMed ID: 15719702 [TBL] [Abstract][Full Text] [Related]
45. [Structural relations in the comparison of methods in clinical chemistry. Application to the study of bias between a centrifugal analysis (Cobas) and the Kodak-Ektachem method]. Auget JL; Richardot P; Gerbet D; Maccario J Ann Biol Clin (Paris); 1984; 42(3):199-205. PubMed ID: 6476489 [TBL] [Abstract][Full Text] [Related]
47. Medical devices; clinical chemistry and clinical toxicology devices; instrumentation for clinical multiplex test systems. Final rule. Food and Drug Administration, HHS Fed Regist; 2005 Mar; 70(46):11867-9. PubMed ID: 15762011 [TBL] [Abstract][Full Text] [Related]
48. Instrumentation and techniques for therapeutic drug monitoring. Dito WR Clin Lab Med; 1981 Sep; 1(3):451-66. PubMed ID: 7049525 [No Abstract] [Full Text] [Related]
49. Elementary, my dear Doctor Watson. Arnaout R Clin Chem; 2012 Jun; 58(6):986-8. PubMed ID: 22522222 [No Abstract] [Full Text] [Related]
50. Medical devices; clinical chemistry and clinical toxicology devices; drug metabolizing enzyme genotyping system. Final rule. Food and Drug Administration, HHS Fed Regist; 2005 Mar; 70(46):11865-7. PubMed ID: 15762010 [TBL] [Abstract][Full Text] [Related]
51. The FDA's perspective on clinical laboratory devices. The premarket review and evaluation process. Aziz KJ; Sliva CA; Gutman SI Am Clin Lab; 1996; 15(1):10-1. PubMed ID: 10163487 [No Abstract] [Full Text] [Related]
52. Comments on practical implications of coexistent different technologies in clinical chemical laboratories. Reply to the letter to the editor by M. Hardel (this J. 30 (1992) 239-240). Kropf J Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):241-2. PubMed ID: 1525257 [No Abstract] [Full Text] [Related]
53. Nanotechnology today: the Oak Ridge Conference explores nanotechnology. Stevenson R Am Clin Lab; 1994 Jul; 13(7):30-1. PubMed ID: 10147385 [No Abstract] [Full Text] [Related]
55. Laboratory automation: total and subtotal. Hawker CD Clin Lab Med; 2007 Dec; 27(4):749-70, vi. PubMed ID: 17950896 [TBL] [Abstract][Full Text] [Related]
56. International Federation of Clinical Chemistry (IFCC): systematic top-down approach to clinical chemistry. Pardue HL; Truchaud A; Osawa K; Place J; Schnipelsky P Ann Biol Clin (Paris); 1994; 52(4):311-20. PubMed ID: 7802356 [TBL] [Abstract][Full Text] [Related]
57. A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia. Vijapurkar M; Ghosh K; Shetty S; McLane MA; Moura da Silva AM; Butera D Haematologica; 2008 May; 93(5):797-8. PubMed ID: 18450741 [No Abstract] [Full Text] [Related]
58. Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer. Kellogg MD; Parker R; Ricupero A; Rifai N Clin Chim Acta; 2005 Apr; 354(1-2):117-22. PubMed ID: 15748607 [TBL] [Abstract][Full Text] [Related]
59. Near infrared reflectance analysis: features and applications in pharmaceutical and biomedical analysis. Corti P; Dreassi E; Leonardi S Farmaco; 1993 Jan; 48(1):3-20. PubMed ID: 8457277 [TBL] [Abstract][Full Text] [Related]
60. Methodology and subspecialty consolidation in the clinical laboratory. Van Lente F Clin Chem; 1997 Jan; 43(1):11-2. PubMed ID: 8990214 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]